Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Free Cash Flow (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Free Cash Flow for 2 consecutive years, with -$10.4 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 45.95% to -$10.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$63.5 million through Dec 2025, down 9.66% year-over-year, with the annual reading at -$63.5 million for FY2025, 9.67% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$10.4 million at Pyxis Oncology, up from -$13.3 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$3.0 million in Q2 2024, with the low at -$22.5 million in Q1 2025.